Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 3Genitourinary 1

Conditions

Kidney Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 106Specimen Handling 87pembrolizumab 81enzalutamide 64Nivolumab 62Gemcitabine 59Docetaxel 51Abiraterone Acetate 44apalutamide 43Radiosurgery 43Androgen Antagonists 43Prednisone 42darolutamide 40Cisplatin 38Biopsy 36Radiotherapy 34cabozantinib 32Carboplatin 30abiraterone 29Pluvicto 29Ipilimumab 29durvalumab 25Leuprolide 24enfortumab vedotin 23X-Rays 23Radiation 23olaparib 20atezolizumab 20Standard of Care 20avelumab 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Technetium Tc 99m Sestamibi × Genitourinary × 90 days × Clear all
NCT03996850 2026-03-13

SPECT/CT for the Characterization of Renal Masses

Jonsson Comprehensive Cancer Center

Active not recruiting
102 enrolled
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡